Skip to content
★ Sign in to follow
SP

Serendex Pharmaceuticals A/S Stock: price and insider trades · Norway

Serendex Pharmaceuticals A/S: what insiders have been doing

We have very little insider data for Serendex Pharmaceuticals A/S so far: the most recent filing dates from 6 January 2016. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by Oslo Børs. They describe what insiders did and are not a recommendation.

Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 6 January 2016
Declarations8 total
  • ●
    Executives(filed)
    96M NOK0Oslo
    128,587,034 shares@ NOK 0.75ShareXOAXOSLO:392583
  • ●
    Executives(filed)
    254,168 NOK0Oslo
    338,890 shares@ NOK 0.75ShareXOAXOSLO:392582
  • ●
    Executives
    0Oslo
    ShareXOAXOSLO:390755
  • ●
    Executives(filed)
    0Oslo
    ShareXOAXOSLO:380866
  • ●
    Executives(filed)
    0Oslo
    XOAXOSLO:374781
  • ●
    Executives(filed)
    0Oslo
    ShareXOAXOSLO:373930
  • ●
    Executives(filed)
    0Oslo
    ShareXOAXOSLO:373189
  • ●
    Executives(filed)
    0Oslo
    XOAXOSLO:370399

8 of 8 declarations

About Serendex Pharmaceuticals A/S

Serendex Pharmaceuticals A/S is a pharmaceutical company focused on developing innovative treatments. It is listed on the XOSL market.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations